Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer

被引:83
作者
Guo, Charles C. [1 ]
Majewski, Tadeusz [1 ]
Zhang, Li [2 ]
Yao, Hui [3 ]
Bondaruk, Jolanta [1 ]
Wang, Yan [1 ]
Zhang, Shizhen [4 ]
Wang, Ziqiao [1 ]
Lee, June Goo [1 ]
Lee, Sangkyou [1 ]
Cogdell, David [1 ]
Zhang, Miao [1 ]
Wei, Peng [4 ]
Grossman, H. Barton [5 ]
Kamat, Ashish [5 ]
Duplisea, Jonathan James [5 ]
Ferguson, James Edward, III [5 ]
Huang, He [1 ]
Dadhania, Vipulkumar [1 ]
Gao, Jianjun [6 ]
Dinney, Colin [5 ]
Weinstein, John N. [3 ]
Baggerly, Keith [3 ]
McConkey, David [7 ]
Czerniak, Bogdan [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[7] Johns Hopkins Univ, Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD USA
来源
CELL REPORTS | 2019年 / 27卷 / 06期
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; UROTHELIAL CARCINOMA; MUTATIONAL PROCESSES; LUMINAL SUBTYPES; EXPRESSION; BREAST; PREDICTS; CHEMOTHERAPY; SIGNATURES; ALIGNMENT;
D O I
10.1016/j.celrep.2019.04.048
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sarcomatoid urothelial bladder cancer (SARC) displays a high propensity for distant metastasis and is associated with short survival. We report a comprehensive genomic analysis of 28 cases of SARC and 84 cases of conventional urothelial carcinoma (UC), with the TCGA cohort of 408 muscleinvasive bladder cancers serving as the reference. SARCs show a distinct mutational landscape, with enrichment of TP53, RB1, and PIK3CA mutations. They are related to the basal molecular subtype of conventional UCs and could be divided into epithelial-basal and more clinically aggressive mesenchymal subsets on the basis of TP63 and its target gene expression levels. Other analyses reveal that SARCs are driven by downregulation of homotypic adherence genes and dysregulation of the EMT network, and nearly half exhibit a heavily infiltrated immune phenotype. Our observations have important implications for prognostication and the development of more effective therapies for this highly lethal variant of bladder cancer.
引用
收藏
页码:1781 / +
页数:17
相关论文
共 72 条
  • [1] A CNGB1 Frameshift Mutation in Papillon and Phalene Dogs with Progressive Retinal Atrophy
    Ahonen, Saija J.
    Arumilli, Meharji
    Lohi, Hannes
    [J]. PLOS ONE, 2013, 8 (08):
  • [2] Signatures of mutational processes in human cancer
    Alexandrov, Ludmil B.
    Nik-Zainal, Serena
    Wedge, David C.
    Aparicio, Samuel A. J. R.
    Behjati, Sam
    Biankin, Andrew V.
    Bignell, Graham R.
    Bolli, Niccolo
    Borg, Ake
    Borresen-Dale, Anne-Lise
    Boyault, Sandrine
    Burkhardt, Birgit
    Butler, Adam P.
    Caldas, Carlos
    Davies, Helen R.
    Desmedt, Christine
    Eils, Roland
    Eyfjord, Jorunn Erla
    Foekens, John A.
    Greaves, Mel
    Hosoda, Fumie
    Hutter, Barbara
    Ilicic, Tomislav
    Imbeaud, Sandrine
    Imielinsk, Marcin
    Jaeger, Natalie
    Jones, David T. W.
    Jones, David
    Knappskog, Stian
    Kool, Marcel
    Lakhani, Sunil R.
    Lopez-Otin, Carlos
    Martin, Sancha
    Munshi, Nikhil C.
    Nakamura, Hiromi
    Northcott, Paul A.
    Pajic, Marina
    Papaemmanuil, Elli
    Paradiso, Angelo
    Pearson, John V.
    Puente, Xose S.
    Raine, Keiran
    Ramakrishna, Manasa
    Richardson, Andrea L.
    Richter, Julia
    Rosenstiel, Philip
    Schlesner, Matthias
    Schumacher, Ton N.
    Span, Paul N.
    Teague, Jon W.
    [J]. NATURE, 2013, 500 (7463) : 415 - +
  • [3] Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
    Amin, Mahul B.
    [J]. MODERN PATHOLOGY, 2009, 22 : S96 - S118
  • [4] [Anonymous], TUMORS URINARY TRACT
  • [5] [Anonymous], CLIN CANC RES
  • [6] [Anonymous], 2013, IARC Cancer Base No. 11: 2012
  • [7] [Anonymous], CELL CYCLE
  • [8] [Anonymous], 2017, AJCC Cancer Staging Manual
  • [9] [Anonymous], BIOINFORMATICS
  • [10] [Anonymous], MOL CELL